Comparison
Aars2 Related Infant Onset Cardiomyopathy Cn381454 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between Aars2 Related Infant Onset Cardiomyopathy CN381454 and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
Aars2 Related Infant Onset Cardiomyopathy Cn381454
A genetic mitochondrial disorder affecting heart muscle development in infants. Requires specialized cardiac care and monitoring. Outlook depends on early diagnosis and intervention.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
Aars2 Related Infant Onset Cardiomyopathy Cn381454
0-1
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
Aars2 Related Infant Onset Cardiomyopathy Cn381454
critical
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
Aars2 Related Infant Onset Cardiomyopathy Cn381454
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
Aars2 Related Infant Onset Cardiomyopathy Cn381454
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
Aars2 Related Infant Onset Cardiomyopathy Cn381454
cardiovascular
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
Aars2 Related Infant Onset Cardiomyopathy Cn381454
cardiovascular
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
aars2-related-infant-onset-cardiomyopathy-CN381454 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Aars2 Related Infant Onset Cardiomyopathy Cn381454 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Infant cardiac dysfunction | Described as affecting infant heart-muscle development and needing specialized cardiac care. | Cardiac disease is not a defining feature in the supplied description. | High |
| Neurodevelopment | Developmental features are not established as the primary presentation from the source. | May include developmental delay, learning difficulty, and sometimes autism-spectrum traits. | High |
| Genetic basis | AARS2-related mitochondrial disorder, categorized here as cardiovascular. | Duplication of chromosome 15q11q13 material linked to the Prader-Willi/Angelman region. | High |
When to favor each condition
Choose Aars2 Related Infant Onset Cardiomyopathy Cn381454 when
Critical heart findings begin in infancy
The supplied onset is 0–1 year and severity is critical, centered on the heart.
Moderate
Genetic testing implicates AARS2
A confirmed AARS2 finding supports this diagnosis over a chromosomal duplication.
High
Care priority is cardiac monitoring
The description specifically calls for specialized cardiac care and monitoring.
High
Choose 15q11q13 Microduplication Syndrome C2675336 when
Developmental delay is the main concern
Delay, learning difficulty, or autism-spectrum traits fit the supplied syndrome description.
Moderate
Testing shows 15q11q13 duplication
A chromosomal duplication result directly supports this condition.
High
Supportive developmental care is primary
Management is described as supportive therapies rather than critical cardiac intervention.
Moderate
How key tests differ
| Test | Aars2 Related Infant Onset Cardiomyopathy Cn381454 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Genetic test | AARS2-related finding may be sought; result must be interpreted clinically. | Chromosomal microarray or equivalent may show 15q11q13 duplication. | The genetic result distinguishes the conditions; neither test result alone replaces diagnosis. |
| Cardiac evaluation | Abnormal heart findings are the described focus, but exact thresholds are not supplied. | A characteristic cardiac abnormality is not established from the source. | Cardiac abnormalities suggest the left condition but require clinician correlation. |
| Developmental assessment | A specific developmental profile is not established here. | Delays, learning difficulty, or autism-spectrum traits may be identified. | Developmental findings favor the right condition without proving it. |
Prognosis comparison
Aars2 Related Infant Onset Cardiomyopathy Cn381454
- Outcome
- Outlook depends on early diagnosis and intervention; survival figures are not established here.
- Factors
- Age at recognition, cardiac severity, and access to specialized care.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Described severity is moderate, but individual developmental outcome is not definitively established.
- Factors
- Learning profile, autism-spectrum traits, and availability of supportive therapies.
Time frame: From infancy or early childhood into a chronic course; precise timelines are unavailable.
Confirmed genetic result, affected body system, and individualized clinical follow-up.
Complications comparison
| Complication | Presentation |
|---|---|
| Cardiac decompensation | A critical risk is implied by infant cardiomyopathy, but frequency is not stated. Not established as a typical complication in the supplied data. Urgent cardiac assessment belongs to the left condition when signs occur. |
| Learning and developmental needs | Not established as a defining complication from the source. Developmental delay and learning difficulty are described features. Educational and therapy needs are more clearly linked to the right condition. |
| Long-term specialist dependence | Chronic course with ongoing cardiac monitoring is described. Chronic course with supportive developmental management is described. Both are chronic, but the responsible specialties differ. |
Patient education highlights
- HighDifferent diagnoses
These names describe different genetic conditions and should not be used interchangeably.
- HighUrgent cardiac symptoms
For suspected AARS2-related cardiomyopathy, breathing difficulty, poor feeding, or color change needs urgent care.
- MediumSupportive care
15q11q13 microduplication is managed supportively; developmental progress varies and needs clinician guidance.